secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeward Ltd. (LFWD)
CIK:        0001607962
Form:       8-K
Filed at:   2024-05-15T23:59:59+00:00
Accession:  0001178913-24-001736
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ReWalk Robotics Q1 2024 revenue surges 340% to $5.3 million, Medicare reimbursement drives growth
--------------------------------------------------------------------------------

- Q1 2024 revenue of $5.3 million, up 340% from $1.2 million in Q1 2023.
- Medicare payment for ReWalk Personal Exoskeleton established; MACs approve 14 claims since fee schedule.
- Net loss widened to $6.3 million ($0.73 per share) from $4.3 million ($0.51 per share) in prior year.
- Cash and equivalents of $20.7 million with no debt; full-year 2024 revenue guidance unchanged at $28-$32 million.
- Gross margin declined to 26.4% from 46.4%, impacted by AlterG integration and low product volumes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1607962/000117891324001736/0001178913-24-001736-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1607962/000117891324001736/zk2431465.htm
  HTML page:      https://secwatch.observer/filing/0001178913-24-001736

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer